Healthpeak Properties (NYSE:DOC) Upgraded to Outperform by BNP Paribas

BNP Paribas upgraded shares of Healthpeak Properties (NYSE:DOCFree Report) from a neutral rating to an outperform rating in a research note published on Friday, Marketbeat.com reports. BNP Paribas currently has $21.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $19.00.

Other research analysts have also issued research reports about the stock. Wells Fargo & Company started coverage on shares of Healthpeak Properties in a report on Monday, March 25th. They issued an equal weight rating and a $19.00 price objective for the company. Compass Point lowered their price target on shares of Healthpeak Properties from $19.00 to $18.00 and set a buy rating for the company in a report on Tuesday, January 2nd. StockNews.com upgraded shares of Healthpeak Properties from a sell rating to a hold rating in a report on Friday, April 5th. Royal Bank of Canada raised their price target on shares of Healthpeak Properties from $21.00 to $22.00 and gave the stock an outperform rating in a report on Wednesday, April 10th. Finally, KeyCorp restated a sector weight rating on shares of Healthpeak Properties in a report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of Hold and an average price target of $18.36.

Read Our Latest Stock Analysis on Healthpeak Properties

Healthpeak Properties Stock Up 2.6 %

Shares of NYSE DOC opened at $18.82 on Friday. The company has a 50 day simple moving average of $16.66 and a 200 day simple moving average of $13.74. The firm has a market cap of $13.35 billion, a PE ratio of 53.77, a price-to-earnings-growth ratio of 1.81 and a beta of 1.02. Healthpeak Properties has a 1 year low of $15.24 and a 1 year high of $22.38. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.67 and a quick ratio of 0.67.

Institutional Trading of Healthpeak Properties

Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC grew its position in Healthpeak Properties by 274.6% in the 4th quarter. Parallel Advisors LLC now owns 4,072 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 2,985 shares during the period. Allspring Global Investments Holdings LLC grew its position in Healthpeak Properties by 42.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 5,750 shares of the real estate investment trust’s stock valued at $70,000 after purchasing an additional 1,712 shares during the period. Envestnet Portfolio Solutions Inc. purchased a new position in Healthpeak Properties during the 3rd quarter worth $124,000. Quadrant Capital Group LLC boosted its holdings in Healthpeak Properties by 645.4% during the 4th quarter. Quadrant Capital Group LLC now owns 9,646 shares of the real estate investment trust’s stock worth $128,000 after acquiring an additional 8,352 shares during the last quarter. Finally, Stratos Wealth Partners LTD. purchased a new position in Healthpeak Properties during the 4th quarter worth $134,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Read More

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.